Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma

By Sugawara Mitsuhiro  

Esophagus, Vol. 10, Iss. 2, 2013-06 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Preoperative chemotherapy with weekly docetaxel plus low-dose cisplatin and 5-fluorouracil for stage II/III squamous cell carcinoma of the esophagus

By Yoshida Takahiro  

Esophagus, Vol. 7, Iss. 2, 2010-06 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases

By Yang Tsai-Shen   Chang Hsien-Khun   Chen Jen-Shi   Lin Yung-Chang   Liau Chi-Ting   Chang Wen-Cheng  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 362-369

Springer Publishing Company

Access to resources Recommend Favorite

Surgery for lymph node metastasis after complete response to chemotherapy and/or radiation therapy in patients with advanced esophageal cancer

By  

Esophagus, Vol. 7, Iss. 3, 2010-09 ,pp. : 177-182

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma

By Kosugi Shin-Ichi   Kanda Tatsuo   Nakagawa Satoru   Ohashi Manabu   Nishimaki Tadashi   Hatakeyama Katsuyoshi  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 886-892

Informa Healthcare

Access to resources Recommend Favorite